Heart Failure
January 16, 2025
The Finer Points of FINEARTS-HF January 16, 2025
Bayer’s FINEARTS-HF study revealed that finerenone could be poised to become the next big heart failure treatment at ESC 2024, and a new series of JACC sub-studies just further strengthened its case. The first of the featured studies revealed that patients treated soon after experiencing a worsening heart failure (WHF) event saw greater benefits. The […]
Cardiac Imaging
January 13, 2025
AI-CCTA Beats SPECT, Again January 13, 2025
A recent study out of UCLA seemed to add to the body of evidence supporting AI-assisted CCTA as an alternative to SPECT for diagnosing obstructive coronary artery disease, although holes in the study suggest that CCTA AI has more to prove To determine if AI-CCTA could hold its own, researchers analyzed CCTA images from 175 […]
Artificial Intelligence
January 9, 2025
AI-ECG’s 2025 Kickoff January 9, 2025
The buzz around artificial intelligence’s impact on cardiology keeps growing louder, and that’s proving to be particularly true in the AI-ECG segment, with 2025 already off to a strong start from ECG startups and researchers alike. One pertinent example is AccurKardia’s recent FDA breakthrough designation for its ECG-based, AI-powered AK+ Guard hyperkalemia detection software. Tackling […]
